TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ:
CGEN), a leading predictive drug discovery company, today announced
that the Company will host a conference call at 10:00 AM ET on Tuesday,
August 4, 2015 to review the second quarter 2015 results. The quarterly
results will be released on the Company’s website (www.cgen.com)
prior to the conference call.
To access the conference call, please dial 1-888-668-9141 from the US,
or + 972-3-918-0609 internationally. The call will also be available via
live webcast through Compugen’s website, located at the following link.
A replay of the conference call will be available beginning
approximately two hours after the completion of the live conference
call. To access the replay, please dial 1-888-326-9310 from the US or
+972-3-925-5925 internationally. The replay will be available through
August 6, 2015.
About Compugen
Compugen is a leading predictive drug discovery company focused on
monoclonal antibodies and therapeutic proteins to address important
unmet needs in the fields of oncology and immunology. The Company
utilizes a broad and continuously growing integrated infrastructure of
proprietary scientific understandings and predictive platforms,
algorithms, machine learning systems and other computational biology
capabilities for the in silico (by computer) prediction and selection of
novel drug target candidates, which are then advanced in its Pipeline
Program. The discovery and development of monoclonal antibody
therapeutic candidates against selected Compugen-discovered novel target
candidates is performed by Compugen’s wholly-owned US subsidiary located
in South San Francisco. The Company's business model includes
collaborations covering the further development and commercialization of
product candidates at various stages from its Pipeline Program and
various forms of research and discovery agreements, in both cases
providing Compugen with potential milestone payments and royalties on
product sales or other forms of revenue sharing. For additional
information, please visit Compugen's corporate website at www.cgen.com.